RET and neoplasm: ALK rearrangements were more frequent in non-drinkers (5.95% vs. 1.05%, P = 0.047) and patients with advanced stages (6.81% vs. 3.26%, P = 0.025), and RET fusions were more common in patients with normal tumor markers (4.92% vs. 1.35%, P = 0.007).